Odyssey Therapeutics to outperform peers in 6 months

Odyssey Therapeutics raised $304 million in its IPO, signaling strong investor confidence in its pipeline. The company's focus on novel therapeutics positions it to gain market share over competitors in the next half-year.

Implied probability (Yes)

68%